Genomic Innovation Antech is actively developing genomic tools to identify drug resistance and improve diagnostic tests, supported by a recent $1.6 million grant. This signals opportunities to position advanced genomic assays and resistance profiling services to veterinary practices seeking precision diagnostics.

Expanded Capabilities With a network spanning 90+ reference laboratories, in-house instruments, digital cytology, rapid assays, data services (local and cloud-based), software support, imaging, and specialist services, there are cross-sell opportunities across testing, data management, and professional support for practices of varying sizes.

Education and Scholarships The launch of the Antech Veterinary Futures Scholarship in partnership with Vet Set Go indicates a focus on professional development and onboarding. This presents a doorway for practices to engage through training programs, sponsored events, and early career outreach to build loyalty.

European and UK Presence Recent introduction of a novel cancer test in the UK and Europe, plus UK-European clinic deployments, suggests a growth channel for international clinics and distributors seeking advanced oncology diagnostics and cross-border support.

Clinical Decision Support Announcements around next-generation diagnostic innovations and vector-borne disease screening tools (trūRapid FOUR) highlight a push toward streamlined, point-of-care decision support. This aligns with opportunities to upsell rapid testing platforms, ongoing monitoring panels, and integrated practice management workflows.